Skip to main content

Advertisement

SpringerLink
Log in

Disability in chronic daily headache: state of the art and future directions

  • Symposium - Chronic Pain and Headache: New Legislation
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Aim of this literature review is to summarize the most relevant research findings on disability in subjects with chronic daily headache (CDH) and chronic migraine (CM) measured with the MIDAS and the HIT-6, and to address issues for further research in the field. Research strategy aimed to find papers published after 2001 that focused on disability in patients with CDH, CM and transformed migraine. Both, general population surveys or clinical series were included if they reported total scores, or distribution of the different disability levels, derived from the MIDAS and/or from the HIT-6. Fifteen papers were selected. Studies demonstrated that these subjects report a remarkable impact on functioning, with high disability scores, and reduced ability in work and non-work activities. Modern definitions of disability conceptualize it as the result of the interaction between a health condition and environmental factors. Research strategies should therefore recognize that disability may represent a global evaluation which should be added to more specific endpoints, using instruments that measure disability in a multi-dimensional way, such as the WHO-DAS II.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sheftell FD, Tepper SJ (2002) New paradigms in the recognition and acute treatment of migraine. Headache 42:58–69

    Article  PubMed  Google Scholar 

  2. D’Amico D, Moschiano F, Usai S, Bussone G (2006) Treatment strategies in the acute therapy of migraine: stratified care and early intervention. Neurol Sci 27:S117–S122

    Article  PubMed  Google Scholar 

  3. D’Amico D, Solari A, Usai S, Progetto Cefalee Lombardia Group et al (2006) Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 26:691–696

    Article  PubMed  Google Scholar 

  4. Lipton RB, Bigal ME, Stewart WF (2005) Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology 65:S50–S58

    Article  PubMed  CAS  Google Scholar 

  5. Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 6:1054–1062

    Article  PubMed  CAS  Google Scholar 

  6. Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L (2007) The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 5:56

    Article  PubMed  Google Scholar 

  7. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19:107–114

    Article  PubMed  CAS  Google Scholar 

  8. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN (2000) Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 88:41–52

    Article  PubMed  CAS  Google Scholar 

  9. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahlöf CG, Dowson A, Tepper S (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12:963–974

    Article  PubMed  CAS  Google Scholar 

  10. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF (2003) Migraine headache disability and health-related quality-of-life: a population based case–control study from England. Cephalalgia 23:441–450

    Article  PubMed  CAS  Google Scholar 

  11. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D’Amico D (2004) Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 25:S105–S107

    Article  PubMed  Google Scholar 

  12. Leonardi M, Steiner T, Scher A, Lipton R (2005) The global burden of migraine: Measuring disability in headache disorders with WHO’s classification of functioning, disability and health (ICF). J Headache Pain 6:429–440

    Article  PubMed  Google Scholar 

  13. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210

    Article  PubMed  Google Scholar 

  14. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8:1–96

    Article  Google Scholar 

  15. Headache Classification. Subcommittee of the International Headache Society (2004) The international classification of headache disorders. Cephalalgia 24:S1–S160

    Google Scholar 

  16. Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746

  17. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised HIS criteria. Neurology 47:871–875

    PubMed  CAS  Google Scholar 

  18. Lanteri-Minet M, Auray JP, El HA, Dartigues JF, Duru G, Henry P, Lucas C, Pradalier A, Chazot G, Gaudin AF (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102:143–149

    Article  PubMed  Google Scholar 

  19. Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD (2003) Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache 43:336–342

    Article  PubMed  Google Scholar 

  20. Meletiche DM, Lofland JH, Young WB (2001) Quality-of-life differences between patients with episodic and transformed migraine. Headache 41:573–578

    Article  PubMed  CAS  Google Scholar 

  21. D’Amico D, Usai S, Grazzi L, Rigamonti A, Solari A, Leone M, Bussone G (2003) Quality of life and disability in primary chronic daily headaches. Neurol Sci 24:S97–S100

    Article  PubMed  Google Scholar 

  22. D’Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G (2005) Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache 45:553–560

    Article  PubMed  Google Scholar 

  23. Bigal ME, Serrano D, Reed M, Lipton RB (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71:559–566

    Article  PubMed  Google Scholar 

  24. Cassidy EM, Tomkins E, Hardiman O, O’Keane V (2003) Factors associated with burden of primary headache in a specialty clinic. Headache 43:638–644

    Article  PubMed  Google Scholar 

  25. Magnoux E, Freeman MA, Zlotnik G (2008) MIDAS and HIT-6 French translation: reliability and correlation between tests. Cephalalgia 28:26–34

    PubMed  CAS  Google Scholar 

  26. Lanteri-Minet M, Chautard MH, Lucas C (2005) Chronic migraine and medication overuse: results of Framig 3, a French population-based survey carried out according to the 2004 IHS classification. Neurology Suppl. 2:A132

  27. Grazzi L, Andrasik F, D’Amico D, Usai S, Kass S, Bussone G (2004) Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up. Headache 44:678–683

    Article  PubMed  Google Scholar 

  28. Andrasik F, Grazzi L, Usai S, Kass S, Bussone G (2010) Disability in chronic migraine with medication overuse: treatment effects through 5 years. Cephalalgia 30:610–614

    PubMed  CAS  Google Scholar 

  29. Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42:796–803

    Article  PubMed  Google Scholar 

  30. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:814–823

    Article  PubMed  Google Scholar 

  31. Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ (2010) Botulinum toxin type A and acute drug costs in migraine with triptan overuse. Can J Neurol Sci 37:588–594

    PubMed  Google Scholar 

  32. Usai S, Grazzi L, D’Amico D, Andrasik F, Bussone G (2008) Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy. Neurol Sci 29:S176–S178

    Article  PubMed  Google Scholar 

  33. Castillo J, Munoz P, Guitera V, Pascual G (1999) Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 39:190–196

    Article  PubMed  CAS  Google Scholar 

  34. Grazzi L, Andrasik F (2006) Medication-overuse headache: description, treatment, and relapse prevention. Curr Pain Headache Rep 10:71–77

    Article  PubMed  Google Scholar 

  35. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81:428–432

    Article  PubMed  CAS  Google Scholar 

  36. D’Amico D (2010) Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials. Neurol Sci 31:S23–S28

    Article  PubMed  Google Scholar 

  37. World Health Organization (2001) The International Classification of Functioning, Disability and Health-ICF. WHO, Geneva

  38. Leonardi M, Bickenbach J, Ustun TB,Kostanjsek N. Chatterji S, MHADIE consortium (2006) The definition of disability: what is in a name? Lancet 368:1219–1221

  39. Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, Alonso J, Cieza A, Svetskova O, Burger H, Racca V, Francescutti C, Vieta E, Kostanjsek N, Raggi A, Leonardi M, Ferrer M, MHADIE consortium (2010) Validation of the World Health Organization Disability Assessment Schedule (WHODAS-2) in patients with chronic diseases. Health Qual Life Outcomes 8:51

  40. Federici S, Meloni F, Mancini A, Lauriola M, Olivetti Belardinelli M (2009) World Health Organisation Disability Assessment Schedule II: Contribution to the Italian validation. Disabil Rehabil 31:553–556

    Article  PubMed  Google Scholar 

  41. Leonardi M, Raggi A, Bussone G, D’Amico D (2010) Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 50:1576–1586

    Article  PubMed  Google Scholar 

  42. Raggi A, Leonardi M, Bussone G, D’Amico D (2011) Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life. Neurol Sci doi:10.1007/s10072-010-0466-3

Download references

Conflict of interest

The authors declare that there is no actual or potential conflict of interest in relation to this article.

Author information

Authors and Affiliations

  1. Headache Center, Neurological Institute “C. Besta” IRCCS Foundation, Via Celoria 11, 20133, Milan, Italy

    Domenico D’Amico, L. Grazzi, S. Usai & G. Bussone

  2. Neurology, Public Health and Disability Unit, Neurological Institute “C. Besta” IRCCS Foundation, Milan, Italy

    A. Raggi & M. Leonardi

Authors
  1. Domenico D’Amico
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Grazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Usai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Raggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Leonardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Bussone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico D’Amico.

Rights and permissions

Reprints and permissions

About this article

Cite this article

D’Amico, D., Grazzi, L., Usai, S. et al. Disability in chronic daily headache: state of the art and future directions. Neurol Sci 32 (Suppl 1), 71–76 (2011). https://doi.org/10.1007/s10072-011-0552-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-011-0552-1

Keywords

Search

Navigation